The New York Times – Business:
The steep decline in oversight has stalled a number of new drug applications. The agency says it is trying to protect its employees but critics say inspectors should be considered essential workers and do their jobs.
Author: RSS Feed
This post first appeared in The New York Times – Business. Read the original article.